医学
心肌梗塞
重症监护医学
危害
输血
没有伤害
贫血
临床试验
人口
心脏病学
内科学
环境卫生
精神科
政治学
法学
作者
Sreshta Paranji,Oghenemega Okoloko,Lauren Coritt,William H. Frishman,Wilbert S. Aronow
标识
DOI:10.1097/crd.0000000000000737
摘要
Anemia in acute myocardial infarctions has been an area of curiosity, with studies looking into clinical outcomes of blood transfusions in this patient population for decades without consistent evidence in the literature pointing in the direction of liberal or conservative transfusion use. With the recent publication of the MINT (Restrictive or Liberal Transfusion Strategy in Myocardial Infarction) trial showing that the liberal transfusion strategy did not reduce the recurrent risk of myocardial infarction but that harm in restrictive strategies cannot be excluded, we look to other literature and trials with different endpoints, which indicate that the liberal transfusion strategies may cause more harm. In this review, we will discuss new evidence as compared to the old for the conservative use of blood transfusions in the setting of myocardial infarctions.
科研通智能强力驱动
Strongly Powered by AbleSci AI